Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
2 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 76.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 228.00 | |
50 mg | In stock | $ 363.00 | |
100 mg | In stock | $ 538.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 62.00 |
Description | GSK8573 is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 (Kd of 1.04 μM). |
Targets&IC50 | BRD9:1.04 μM (Kd) |
Molecular Weight | 323.39 |
Formula | C20H21NO3 |
CAS No. | 1693766-04-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22 mg/mL (68.03 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK8573 1693766-04-9 Chromatin/Epigenetic Epigenetic Reader Domain GSK 8573 BRD9 Inhibitor BAZ2B GSK-8573 control compound biological inhibit BAZ2A inhibitor